Dementia with Lewy bodies appears t...

Dementia with Lewy bodies appears to be the secondary most common form of dementia, accounting for about single in kind in five cases. The condition is characterized by the agency of dementia accompanied by delirium, visual hallucinations, and parkinsonism. Other often met with symptoms include syncope, falls, be still disorders, and depression. The air of both Lewy bodies and amyloid plaques with deficiencies in one as well as the other acetylcholine and dopamine neurotransmitters hints that dementia with Lewy bodies delineates the middle of a disease image ranging from Alzheimer's disease to Parkinson's disease. The diagnosis of dementia with Lewy bodies is based in succession clinical features and exclusion of other diagnoses. Individualized behavioral, environmental, and pharmacologic therapies are used to alleviate symptoms and support patients and their families. Cholinesterase inhibitors are more effective in patients who have dementia with Lewy bodies than in those with Alzheimer's disease. by conversion patients who have dementia with Lewy bodies do not reply as well to antiparkinsonian medications. Anticholinergic medications should be avoided because they exacerbate the symptoms of dementia. Traditional antipsychotic medications can precipitate simple reactions and may double or triple the rate of mortality in patients who have dementia with Lewy bodies.

**********

Dementia with Lewy bodies was first described in 1984 by way of Kosaka and colleagues, (1) who reported finding Lewy bodies (i.e., eosinophilic cytoplasmic inclusions in the brainstems of patients affected according to Parkinson's disease) throughout the cortexes of more [i]or[/i] less patients with dementia, rather than the neuritic plaques and neurofibrillary tangles characteristic of Alzheimer's disease. (2) The [i]clavis[/i] features of dementia with Lewy bodies were clarified in the 1996 consensus guidelines (3) published after the first international workshop of the Consortium upon Dementia with Lewy Bodies (Table 1 (3))

[TABLE 1 OMITTED]

Although understanding of dementia with Lewy bodies is still evolving, family physicians must be able to recognize and appropriately manage this condition; the treatment and prognosis differ from those of Alzheimer's disease, Parkinson's disease with dementia, and the vascular dementias. This is especially important because of the sharp reaction to neuroleptic medications associated with dementia with Lewy bodies and the greater rejoinder to cholinesterase inhibitors. (4)

Epidemiology

Dementia with Lewy bodies is the secondary most common histopathology found in dementia, outvieed only by Alzheimer's disease. (5) At least 5 percent of noninstitutionalized adults 85 years and older are believed to have dementia with Lewy bodies, and the disease give an account ofs approximately 22 percent of all patients with dementia. (4) The number of cases is count uponed to increase as the population ages and as dementia with Lewy bodies is increasingly recognized in the differential diagnosis of dementia. To date, no specific risk factors for dementia with Lewy bodies have been identified. (46)

Pathology

The relationships among dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease with dementia are difficult to define because the rife evidence supports different points of view. a certain number of experts believe that dementia with Lewy bodies is related to Alzheimer's disease or Parkinson's disease with dementia, if it were not that the emerging consensus is that dementia with Lewy bodies is a distinct pathologic entity somewhere between the sum of two units (7)

Pathologically, classical Alzheimer's disease is associated with amyloid plaques and neurofibrillary tangles distributed in the parietal, temporal, and parieto-occipital cortex, whereas Parkinson's disease is associated with Lewy bodies primarily in the subcortical regions of the brain, predominantly in the midbrain substantia nigra and locus ceruleus. (8) In contrast, dementia with Lewy bodies is characterized by means of the presence of Lewy bodies in the subcortical and cortical (frontotemporal) regions of the brain, as well as amyloid plaques. Neurofibrillary tangles are les usual in dementia with Lewy bodies. (48)

latter research has shown that Lewy bodies are eosinophilic cytoplasmic inclusions that contain deposits of a protein called alpha-synuclein. (479 )Both Parkinson's disease with dementia and dementia with Lewy bodies are synucleinopathies, meaning they are neurodegenerative conditions associated with abnormal aggregations of alpha-synuclein. (10) reciprocally Alzheimer's disease is an amyloidopathy with extracellular senile plaques containing beta amyloid and/or a tauopathy with neurofibrillary tangles of the microtubular protein tau. (489) Dementia with Lewy bodies usually existings with both Lewy bodies and senile plaques.

Biochemically, dementia with Lewy bodies is associated with deficits in as well-as; not only-but also; not only-but; not alone-but acetylcholine and dopamine, which are the primary neurotransmitter deficits in Alzheimer's disease and Parkinson's disease, respectively. (11) Thus, clinically, pathologically, and biochemically, dementia with Lewy bodies appears to fall somewhere in the middle of a disease image ranging from Alzheimer's disease to Parkinson's disease (Figure 1)